Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MONITOR (Molecular Assessment and Identification of ctDNA and Optimizing Treatment for HR-positive, Her2-negative Metastatic Breast Cancer)

NCT07802626 is registered in ClinicalTrials.gov with SWOG Cancer Research Network as lead sponsor.

NCT NCT07802626
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07802626 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MONITOR (Molecular Assessment and Identification of ctDNA and Optimizing Treatment for HR-positive, Her2-negative Metastatic Breast Cancer)
Lead sponsor
SWOG Cancer Research Network
Phase
Phase 3
Overall status
Not yet recruiting
Start date
October 30, 2026
Completion date
October 30, 2035
Enrollment
1,084 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hr positive/her-2 negative breast cancer